Proteins and peptides now constitute a major proportion of therapeutic modalities being pursued for the treatment of various diseases 1. Nearly 30% of all drugs approved by the US Food and Drug ...
Drug administration to neonates often requires prolonged intravenous access, mostly because of either poor gastrointestinal function or poor oral bioavailability of the drugs being used. Transdermal ...
NEW YORK, April 3, 2017 /PRNewswire/ -- The global topical drug delivery market is poised to reach USD 125.88 billion by 2021 from USD 92.40 billion in 2016, growing at a CAGR of 6.4% from 2016 to ...
A review in the Annals of Pharmacotherapy examined the literature on alternative routes of administration for antipsychotic and antidepressant medications via inhaled, intranasal, buccal, sublingual, ...
June 7, 2010 — Low-dose, transdermal hormone replacement therapy (HRT) does not appear to increase the risk for stroke compared with no HRT use, according to a study published June 3 in the BMJ. In ...
The "Transdermal Drug Delivery - Technologies, Markets, and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report deals with transdermal drug ...
Transdermal drug delivery is an alternative to oral or invasive drug delivery systems. This approach is associated with several advantages including its ability to bypass first-pass metabolism and its ...
Ethosomes are ethanolic nanovesicles that possess abundant amount of ethanol in its core which provides fluidity to the lipid bilayers and thus by this effect, improves the delivery of molecules into ...
The global transdermal drug delivery systems market size was US$ 55100.33 million in 2021. The global transdermal drug delivery systems market size is forecast to reach US$ 88,422.40 million by 2030, ...
Hormone Replacement Therapy (HRT) via transdermal delivery is found to be highly effective for mental health problems like anxiety and depression in post-menopausal women. The findings come from a new ...
CLEVELAND, Ohio (Oct 21, 2025)—Hormone therapy–oral and transdermal–remains the most effective treatment for such bothersome menopause symptoms as hot flashes and is generally considered safe for most ...